Sean Shih-Yao Liu1, Lynne A Opperman, Peter H Buschang. 1. Department of Orthodontics and Oral Facial Genetics, School of Dentistry, Indiana University, Indianapolis, IN 46202, USA. SSLiu@iupui.edu
Abstract
INTRODUCTION: The goal of this study was to evaluate whether human recombinant bone morphogenetic protein-2 (rhBMP-2) enhances sutural bone formation or causes premature sutural fusion. METHODS: Thirty 6-week-old rabbits underwent midsagittal sutural expansion. The animals were randomly assigned to receive 0 (control), 0.1 mg per milliliter, or 0.4 mg per milliliter of rhBMP-2, delivered by an absorbable collagen sponge placed over the suture. A 100-g constant force was delivered for 33 days by using a nickel-titanium spring to expand the suture between 2 miniscrew implants anchored in the frontal bone. At days 10, 20, and 30, sutural separation was evaluated and modeled over time as polynomials by using multilevel statistical procedures. Bone formation and sutural gaps were analyzed histomorphometrically between days 10 and 20 and days 20 and 30. RESULTS: The control group showed significantly greater overall sutural bone formation than did the 2 rhBMP-2 groups. Over time, bone formation decreased significantly in all groups. Between days 10 and 20, the 0.4 mg per milliliter group produced significantly more (58%) bone than did the 0.1 mg per milliliter group; there were no significant differences in bone formation between the 2 experimental groups between days 20 and 30. Both 0.1 and 0.4 mg per milliliter of rhBMP-2 in the absorbable collagen sponge caused premature fusion by forming a bony bridge connecting the ectocranial aspect of the sutural margins. Premature fusion significantly reduced sutural separation between 10 and 30 days (to 56% and 62% of control values for the 0.1 and 0.4 mg per milliliter groups, respectively). There were no significant differences in sutural separation between the 0.1 and 0.4 mg per milliliter groups. CONCLUSIONS: Compared with the 0.1 mg per milliliter group, 0.4 mg per milliliter of rhBMP-2 accelerated sutural bone formation between days 10 and 20. After 10 to 20 days, rhBMP-2 in the absorbable collagen sponge caused premature sutural fusion, despite the constant expansion forces.
INTRODUCTION: The goal of this study was to evaluate whether human recombinant bone morphogenetic protein-2 (rhBMP-2) enhances sutural bone formation or causes premature sutural fusion. METHODS: Thirty 6-week-old rabbits underwent midsagittal sutural expansion. The animals were randomly assigned to receive 0 (control), 0.1 mg per milliliter, or 0.4 mg per milliliter of rhBMP-2, delivered by an absorbable collagen sponge placed over the suture. A 100-g constant force was delivered for 33 days by using a nickel-titanium spring to expand the suture between 2 miniscrew implants anchored in the frontal bone. At days 10, 20, and 30, sutural separation was evaluated and modeled over time as polynomials by using multilevel statistical procedures. Bone formation and sutural gaps were analyzed histomorphometrically between days 10 and 20 and days 20 and 30. RESULTS: The control group showed significantly greater overall sutural bone formation than did the 2 rhBMP-2 groups. Over time, bone formation decreased significantly in all groups. Between days 10 and 20, the 0.4 mg per milliliter group produced significantly more (58%) bone than did the 0.1 mg per milliliter group; there were no significant differences in bone formation between the 2 experimental groups between days 20 and 30. Both 0.1 and 0.4 mg per milliliter of rhBMP-2 in the absorbable collagen sponge caused premature fusion by forming a bony bridge connecting the ectocranial aspect of the sutural margins. Premature fusion significantly reduced sutural separation between 10 and 30 days (to 56% and 62% of control values for the 0.1 and 0.4 mg per milliliter groups, respectively). There were no significant differences in sutural separation between the 0.1 and 0.4 mg per milliliter groups. CONCLUSIONS: Compared with the 0.1 mg per milliliter group, 0.4 mg per milliliter of rhBMP-2 accelerated sutural bone formation between days 10 and 20. After 10 to 20 days, rhBMP-2 in the absorbable collagen sponge caused premature sutural fusion, despite the constant expansion forces.
Authors: Christopher D Lopez; Paulo G Coelho; Lukasz Witek; Andrea Torroni; Michael I Greenberg; Dean L Cuadrado; Audrey M Guarino; Jonathan M Bekisz; Bruce N Cronstein; Roberto L Flores Journal: Plast Reconstr Surg Date: 2019-08 Impact factor: 4.730
Authors: Chen Shen; Lukasz Witek; Roberto L Flores; Nick Tovar; Andrea Torroni; Paulo G Coelho; F Kurtis Kasper; Mark Wong; Simon Young Journal: Tissue Eng Part A Date: 2020-10-01 Impact factor: 3.845
Authors: Maxime M Wang; Roberto L Flores; Lukasz Witek; Andrea Torroni; Amel Ibrahim; Zhong Wang; Hannah A Liss; Bruce N Cronstein; Christopher D Lopez; Samantha G Maliha; Paulo G Coelho Journal: Sci Rep Date: 2019-12-05 Impact factor: 4.379
Authors: Burcu A Altan; Isa M Kara; Ruhi Nalcaci; Fatih Ozan; Serif M Erdogan; Mahmut M Ozkut; Sevinc Inan Journal: Angle Orthod Date: 2012-08-20 Impact factor: 2.079